إعلان
إعلان
NEUP
Neuphoria Therapeutics Inc. Common Stock
4.17
USDبرعاية
+0.10
+2.58%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
4.24
+0.07
+1.65%
تقارير أرباح NEUP
النسبة الإيجابية المفاجئة
NEUP تفوق 0 من 2 آخر التقديرات.
%
التقرير التالي
بيانات التقرير القادم
١٢ فبراير ٢٠٢٦
Estimate for Q2 26 (Revenue/ EPS)
--
/-$1.49
التغير الضمني من Q1 26 (Revenue/ EPS)
--
/-66.21%
التغير الضمني من Q2 25 (Revenue/ EPS)
--
/--
Neuphoria Therapeutics Inc. Common Stock earnings per share and revenue
On ١٤ نوفمبر ٢٠٢٥, NEUP reported earnings of -4.41 USD per share (EPS) for Q1 26, missing the estimate of -1.35 USD, resulting in a -225.89% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 المحللين forecast an EPS of -1.49 USD, with revenue projected to reach -- USD, implying an نقصان of -66.21% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Neuphoria Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Neuphoria Therapeutics Inc. Common Stock reported EPS of -$4.41, missing estimates by -225.89%, and revenue of $0.00, 0% as expectations.
How did the market react to Neuphoria Therapeutics Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 0.84%, changed from $4.75 before the earnings release to $4.79 the day after.
When is Neuphoria Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٢ فبراير ٢٠٢٦.
What are the forecasts for Neuphoria Therapeutics Inc. Common Stock's next earnings report?
Based on 5
المحللين, Neuphoria Therapeutics Inc. Common Stock is expected to report EPS of -$1.49 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان